Highlights HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Market Closed - Swiss Exchange Other stock markets 11:30:35 2023-12-05 am EST			5-day change	1st Jan Change
174.2 ^CHF	+0.23%		0.00%	-13.33%

Dec. 01	AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	MT
Nov. 21	Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	Nov. 30	MT
HBM Healthcare Investments Launches Share Buyback	Oct. 16	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Oct. 16	CI
HBM Healthcare Investments Logs Higher Fiscal H1 Loss	Oct. 16	MT
HBM Healthcare Investments Flags Fiscal H1 Loss	Oct. 03	MT
HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2023	Jul. 21	CI
HBM Healthcare Investments AG commences an Equity Buyback Plan under the authorization approved on June 10, 2022.	Jul. 05	CI
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	Jun. 26	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2023	May. 26	CI
HBM Healthcare Investments' Loss Widens in FY23	May. 12	MT
HBM Healthcare Invests $12 Million into US-based ArriVent Biopharma	Mar. 28	MT
HBM Healthcare Investments' Portfolio Company Mineralys Therapeutics Completes $192 Million IPO	Feb. 13	MT
Successful IPO of HBM portfolio company Mineralys Therapeutics	Feb. 13	EQ
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	Jan. 20	CI
HBM Healthcare Investments : Quarterly Report December 2022	Jan. 20	PU
HBM Healthcare Swings To Loss In Fiscal Q3 On Negative Currency Effects	Jan. 20	MT
HBM Healthcare Investments publishes Quarterly Report with key figures for the quarter ended 31 December 2022 and for the first nine months of the 2022/2023 financial year	Jan. 20	EQ
HBM Healthcare Investments Flags Fiscal Nine-month Loss After NAV Dips	Jan. 03	MT
HBM Healthcare Swings To Fiscal H1 Loss On Reduced Share Price Of Portfolio Company Cathay Biotech	2022	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	2022	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Highlights HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Highlights

Filters